Statin-associated myopathy in pediatric settings: Myth or fact?

We read with interest the report titled Statin-Associated Myopathy in a Pediatric Preventive Cardiology Practice.1 We have collected data regarding 122 pediatric patients (median age, 12.9 years; range, 6-18) affected by heterozygous familial hypercholesterolemia without other comorbidity receiving statin therapy during a median period of observation of 29 months (range, 12-60). Laboratory values including creatine kinase were obtained at baseline and at follow-up visits (regularly every about 6 months).

http://ift.tt/2wXPnlE